37,650 paid endpoints are listed. 23,105 answered a real 402 at the last check.
Every x402 endpoint on the Coinbase Bazaar and x402scan, probed unpaid every six hours. A listing tells you the price a seller wrote down. This tells you whether the endpoint is reachable, whether it charges what it declared, and how fast it answers. Ranked by an assay score out of 100.
Last check 2026-09-30 12:50 UTC · 37,650 probed
ScoreEndpointPrice · networkLatencyPayers 30dUptimeLast 30 probes
- 75api.magentlab.com/api/calc/mulbstaGuo 2019 MuLBSTA viral pneumonia mortality score. Caller-assigned multilobular infiltrates (5), lymphocyte count ≤0.8 ×10^9/L (4), bacterial coinfection (4), exclusive smoking (never 0, former 2, current 3), hypertension (2), and age ≥60 (2). Max 20. Low 0-11, high ≥12. magent does not read imaging or assign smoking history. Not a viral-species diagnosis or treatment order.
$0.005$0.007 Base1607 ms1 payers100% up - 75api.magentlab.com/api/calc/psi_portFine 1997 Pneumonia Severity Index (PSI/PORT): Class I if age ≤50 and no neoplastic, liver, CHF, cerebrovascular, or renal disease, no AMS, HR <125, RR <30, SBP >=90, and temperature 35 to <40 C. Otherwise Table 2 points (age, or age-10 if female, plus comorbidity, vital-sign, and laboratory weights) map to classes II-V. Always returns the Table 2 total. Not a medical device and not a site-of-care decision.
$0.005$0.007 Base1480 ms1 payers100% up - 75api.magentlab.com/api/calc/crb65Lim 2003 CRB-65 for community-acquired pneumonia: confusion, respiratory rate ≥30/min, low blood pressure (SBP <90 or DBP ≤60), and age ≥65; 1 point each, max 4. No urea. Score only; no mortality percentages or site-of-care bands. Not a diagnosis. Not CURB-65. Caller assigns the C, R, and B flags; magent does not convert BUN or take BP numbers.
$0.005$0.007 Base1137 ms1 payers100% up - 75api.magentlab.com/api/calc/curb65CURB-65 pneumonia severity from age and discrete clinical flags. Deterministic published score with citation; not a treatment recommendation.
$0.005$0.007 Base1244 ms1 payers100% up - 75api.magentlab.com/api/calc/shanghaiAntzelevitch 2016 Shanghai Score System (Table 2) for Brugada syndrome. Caller assigns ECG (spontaneous type 1 3.5, fever type 1 3, drug-converted type 2/3 2; required; highest only), clinical history (0–3), family history (0–2), and pathogenic BrS-gene mutation (0.5). Bands: probable_definite ≥3.5, possible 2–3. magent does not read tracings. Not a diagnosis or ICD indication. Not the ERS Table 5 score.
$0.005$0.007 Base1239 ms1 payers100% up - 75api.magentlab.com/api/calc/subtle_stemiDriver 2017 4-variable formula for normal-variant STE in V2-V4 (early repolarization) versus subtle LAD occlusion: formula_value = 0.052*QTc_ms - 0.151*QRS_V2_mm - 0.268*R_V4_mm + 1.062*STE60_V3_mm, 3 decimals. lad_occlusion_suggested is true iff the value is ≥18.2 (derivation highest-accuracy cutpoint). Intended only when ≥1 mm STE in V2-V4 without obvious occlusion features. magent does not read the ECG. Not a STEMI diagnosis, cath-lab order, or 3-variable formula. Not a medical device.
$0.005$0.007 Base1319 ms1 payers100% up - 75api.magentlab.com/api/calc/tisdaleTisdale 2013 QT prolongation risk score (Table 5): age ≥68 (1), female (1), loop diuretic (1), potassium ≤3.5 mmol/L (2), admission QTc ≥450 ms (2), acute MI (2), sepsis (3), heart failure (3), one QTc-prolonging drug (3) plus ≥2 drugs (3 stacked; max 21). Returns bands 0-6 / 7-10 / ≥11. Deterministic published arithmetic with citation; not a medical device, not a drug-stop protocol, and not a TdP diagnosis.
$0.005$0.007 Base1320 ms1 payers100% up - 75api.magentlab.com/api/calc/ascvd_vhrAHA/ACC 2018 Table 4 very high-risk ASCVD for known clinical ASCVD. Very high-risk if ≥2 major events (recent ACS, prior MI, ischemic stroke, symptomatic PAD) or 1 major event and ≥2 high-risk conditions (age ≥65, heterozygous FH, CABG/PCI outside those events, diabetes, hypertension, CKD eGFR 15-59, current smoking, LDL-C ≥100 on max statin and ezetimibe, congestive HF). Not PCE. Not a statin, ezetimibe, or PCSK9 order. magent does not diagnose ASCVD or measure ABI or LDL-C.
$0.005$0.007 Base1154 ms1 payers100% up - 75api.magentlab.com/api/calc/ascvd_pceGoff 2013 ACC/AHA pooled-cohort 10-year hard ASCVD percent for age 40-79 from sex, caller-assigned white or african_american cohort, total and HDL cholesterol, treated or untreated systolic BP, smoking, and diabetes. Table A coefficients. Caller assigns cohort; magent does not assign race and does not apply Recommendation 2 as a silent swap. Not PREVENT 2024, not Framingham CHD, not SCORE2, not a diagnosis or statin order. magent does not assay lipids.
$0.005$0.007 Base1280 ms1 payers100% up - 75api.magentlab.com/api/calc/score2_diabetesESC 2023 SCORE2-Diabetes 10-year fatal plus non-fatal CVD percent for type 2 diabetes, age 40-79, from sex, smoking, systolic BP, total and HDL cholesterol, age at diagnosis, IFCC HbA1c, eGFR, and European geographic risk region. Not SCORE2, not SCORE2-OP, not a diagnosis or statin order. magent does not assay lipids, HbA1c, or eGFR.
$0.005$0.007 Base1252 ms1 payers100% up - 75api.magentlab.com/api/calc/score2_opESC 2021 SCORE2-OP 10-year fatal plus non-fatal CVD percent for age 70-89 from sex, current smoking, diabetes, systolic BP, non-HDL cholesterol, and European geographic risk region (low, moderate, high, very_high). Published sex-specific Table 2 coefficients and region scale1/scale2. Not SCORE2, not SCORE2-Diabetes, not 2013 PCE, not PREVENT, not a diagnosis or statin order. magent does not assay lipids.
$0.005$0.007 Base1250 ms1 payers100% up - 75api.magentlab.com/api/calc/score2ESC 2021 SCORE2 10-year fatal plus non-fatal CVD percent for age 40-69 from sex, current smoking, systolic BP, non-HDL cholesterol, and European geographic risk region (low, moderate, high, very_high). Published sex-specific coefficients and region scale1/scale2. Not SCORE2-OP, not SCORE2-Diabetes, not 2013 PCE, not Reynolds, not a diagnosis or statin order. magent does not assay lipids.
$0.005$0.007 Base1001 ms1 payers100% up - 75api.magentlab.com/api/calc/reynoldsRidker JAMA 2007 Reynolds Risk Score, women Model B only: 10-year CVD percent from age, SBP, hsCRP, total cholesterol, HDL-C, HbA1c if diabetic, current smoking, and parental MI before 60. Natural-log Box formula. Not men (Ridker 2008), not ATP-III, not 2013 PCE, not a diagnosis or statin order. magent does not assay lipids or hsCRP.
$0.005$0.007 Base1119 ms1 payers100% up - 75api.magentlab.com/api/calc/framingham_chdWilson 1998 Framingham 10-year CHD from sex-specific total-cholesterol point sheets: age 30-74, TC, HDL, JNC-V blood pressure, diabetes, and smoking. Deterministic published arithmetic with citation. Not a statin order, not ATP-III 2001, not pooled-cohort ASCVD. magent does not measure lipids or BP.
$0.005$0.007 Base1277 ms1 payers100% up - 75api.magentlab.com/api/calc/martin_ldlMartin 2013 estimated LDL-C from total cholesterol, HDL, and triglycerides in mg/dL. Adjustable TG:VLDL-C factor from the published 180-cell table by non-HDL-C and TG strata. Not Friedewald factor 5, not Sampson, not a diagnosis or statin order.
$0.005$0.007 Base1202 ms1 payers100% up - 75api.magentlab.com/api/calc/miller_esrAdult maximum normal erythrocyte sedimentation rate (mm/h, 98th percentile approximation) from age and sex (Miller 1983). Men: age/2. Women: (age + 10)/2. Deterministic published arithmetic with citation. Returns the threshold only; not a diagnosis, not a measured ESR, and not Wener 2000 CRP. magent does not measure ESR.
$0.005$0.007 Base1870 ms1 payers100% up - 75api.magentlab.com/api/calc/irae_hypothyroidismBrahmer 2018 ASCO Table 4.1.1 irAE primary hypothyroidism grade from tsh_miu_l (0.01-150 mIU/L) and three caller-assigned flags. First-match: grade 3 if severe_or_life_threatening or unable_to_perform_adl (paper G3-4 as grade 3); else 2 if moderate_symptoms or TSH >= 10; else 1 if TSH < 10. Returns icpi_action continue (grade 1) or hold_until_baseline (grade 2 or 3). Not hyperthyroidism (Table 4.1.2). magent does not assay TSH/FT4. Not a medical device, not a diagnosis, not a levothyroxine dose.
$0.005$0.007 Base1311 ms1 payers100% up - 75api.magentlab.com/api/calc/myxedema_comaPopoveniuc 2014 myxedema coma points from caller-assigned bands: thermoregulatory 0/10/20; CNS 0/10/15/20/30; GI 0/5/15/20; precipitant 10; bradycardia 0/10/20/30 plus other EKG 10, effusion 10, pulmonary edema 15, cardiomegaly 15, hypotension 20; five metabolic flags 10 each. Max 230. ≥60 potentially diagnostic; 45–59 at risk. Not a diagnosis or thyroid-hormone order. magent does not measure temperature, GCS, or labs.
$0.005$0.007 Base1126 ms1 payers100% up - 75api.magentlab.com/api/calc/adrogue_madiasAdrogué–Madias change in serum sodium after 1 L of infusate from TBW (child 0.6; adult male 0.6; adult female 0.5; elderly male 0.5; elderly female 0.45) and infusate Na plus K. Deterministic published arithmetic with citation; not a correction-rate order or infusion protocol.
$0.005$0.007 Base1152 ms1 payers100% up - 75api.magentlab.com/api/calc/stool_osmotic_gapEherer–Fordtran 1992 fecal osmotic gap: stool osmolality minus 2×(stool Na + stool K). Assumed stool osm 290 mOsm/kg when measured osm is omitted. Deterministic published arithmetic with citation; not a diagnosis of osmotic versus secretory diarrhea.
$0.005$0.007 Base1923 ms1 payers100% up - 75api.magentlab.com/api/calc/dka_mpmEfstathiou 2002 DKA-MPM. Six caller-assigned flags: severe coexisting disease at presentation (+6), pH <7.0 at presentation (+4), regular insulin >50 IU in the first 12 h (+4), glucose >16.7 mmol/L after 12 h (+4), depressed mental state after 24 h (+4), fever after 24 h (+3). Max 25. Published in-hospital death 0.86% for scores 0–14 and 93.3% for 19–25; scores 15–18 return the total only. magent does not assay pH or glucose. Not a DKA treatment or insulin-dose order. Not a medical device.
$0.005$0.007 Base1765 ms1 payers100% up - 75api.magentlab.com/api/calc/estimated_ethanolFasting Watson 1981 theoretical Co from ingested ethanol grams and sex-specific Watson 1980 total body water. Blood-water fraction 0.80; absorbed fraction 1. Fasting Widmark-type estimate only. Ethanol only; not a medicolegal BAC or treatment dose.
$0.005$0.007 Base1965 ms1 payers100% up - 75api.magentlab.com/api/calc/abgBerend 2014 physiological acid-base assessment. Labels acidemia or alkalemia, primary metabolic vs respiratory process, anion gap (Na-Cl-HCO3), optional albumin-corrected gap, and printed delta-delta. Not a diagnosis, ventilator order, bicarbonate dose, or blood-gas assay.
$0.005$0.007 Base1448 ms1 payers100% up - 75api.magentlab.com/api/calc/anion_gapSerum anion gap from sodium, chloride, and bicarbonate, with or without potassium. formula=without_k or formula=with_k is required; magent does not pick one. Deterministic Emmett–Narins 1977 arithmetic with citation. Not a diagnosis, albumin-corrected gap (Figge/Fencl), or delta gap.
$0.005$0.007 Base1358 ms1 payers100% up - 75api.magentlab.com/api/calc/wintersWinters' formula for expected PCO2 in metabolic acidosis: 1.5 × bicarbonate + 8 mm Hg, with a published ±2 mm Hg range. Optional comparison of measured PaCO2 to that band. Deterministic Albert–Winters 1967 arithmetic with citation; not a treatment target or a metabolic alkalosis formula.
$0.005$0.007 Base1291 ms1 payers100% up - 75api.magentlab.com/api/calc/sodium_deficitSodium deficit from weight, sex, and measured Na using Adrogué–Madias TBW (0.6 male / 0.5 female). Deterministic published arithmetic with citation; not a sodium infusion protocol.
$0.005$0.007 Base1281 ms1 payers100% up - 75api.magentlab.com/api/calc/idf_darHassanein 2021 IDF-DAR fasting risk table: type 1 scores 1; duration ≥10 scores 1; hypoglycemia 0/1/3.5/5.5/6.5; HbA1c band 0/1/2; treatment 0/0.5/1/1.5/2/2.5/3; SMBG 0/1/2; DKA/HONC 0/1/2/3; MVD 0/2/6.5; eGFR band 0/2/4/6.5; pregnancy 0/3.5/6.5; frailty 0/3.5/6.5; labour 0/2/4; prior negative Ramadan 1; fasting ≥16 h 1. Low 0–3, moderate 3.5–6, high >6. Caller-assigned; not a fasting order or insulin dose.
$0.005$0.007 Base1842 ms1 payers100% up - 75api.magentlab.com/api/calc/hypoglycemia_risk_scoreKarter 2017 Figure 2 T2D 12-month hypoglycemia-related ED/hospital-use risk from prior_hypo_ed_hospital_count (0-20), ed_visits_12mo (0-50), insulin, sulfonylurea, severe_or_esrd (dialysis or CKD 4-5, eGFR <=29), and age_lt_77. First-match 6 options: >=3 prior or 1-2 plus insulin = high (>5%); remaining rows intermediate (1-5%) or low (<1%). Not a points sum. magent does not assay glucose. Not a diagnosis. Not an insulin dose.
$0.005$0.007 Base1426 ms1 payers100% up - 75api.magentlab.com/api/calc/irae_diabetesBrahmer 2018 ASCO Table 4.4 irAE diabetes from glucose_mg_dl (50-1000, mg/dL only) plus caller ketosis, t1dm, severe_unable_adl, and life_threatening. First-match: G4 if life_threatening or glucose >500; else G3 if severe_unable_adl or glucose >250; else G2 if ketosis or t1dm or glucose >160; else G1 if glucose >99; else G0. ICI continue (0-1), hold_until_control (2), hold_admit (3-4). Not DKA diagnostic criteria. magent does not assay glucose. Not a diagnosis. Not an insulin dose.
$0.005$0.007 Base2178 ms1 payers100% up - 75api.magentlab.com/api/calc/cambridge_diabetesGriffin 2000 Cambridge logistic risk of undetected type 2 diabetes. p = 1/(1+e^(-λ)); λ = -6.322 - 0.879 if female + 1.222 antihypertensive + 2.191 steroids + 0.063×age + BMI band (<25 0; 25 to <27.5 0.699; 27.5 to <30 1.97; ≥30 2.518) + family (parent or sibling 0.728; parent and sibling 0.753) + smoking (former -0.218; current 0.855). Age 40-64. Probability 0-1. Not FINDRISC, not ADA, not a glucose assay, not a diagnosis.
$0.005$0.007 Base2080 ms1 payers100% up - 75api.magentlab.com/api/calc/ausdriskChen 2010 AUSDRISK Box 3 waist model (not BMI). Male 3; age 18-34 0, 35-44 2, 45-54 4, 55-64 6, >=65 8; ancestry atsi_or_asian or southern_european_or_pacific 2 (caller-assigned); parental diabetes 3; high glucose 6; antihypertensives 2; current smoker 2; physically inactive 2; waist cat1/2/3 = 0/4/7 (ATSI/Asian vs other cutoffs). Max 35. at_risk iff score>=12. Not a diagnosis. Not FINDRISC.
$0.005$0.007 Base1361 ms1 payers100% up - 75api.magentlab.com/api/calc/findriscLindström 2003 Finnish diabetes risk score (FINDRISC). Original seven-item 0–20 score, cutoff ≥9: age (<45 → 0, 45–54 → 2, 55–64 → 3, ≥65 → 4); BMI (<25 → 0, 25–30 → 1, >30 → 3); sex-specific waist; BP medication 2; high-glucose history 5; daily 30-min activity 0 else 2; daily vegetables 0 else 1. Returns score and at_risk. Not a diabetes diagnosis and not the later family-history revision.
$0.005$0.007 Base1248 ms1 payers100% up - 75api.magentlab.com/api/calc/cpriSaisho 2011 CPR index: serum C-peptide (ng/mL) / plasma glucose (mg/dL) * 100, two decimals. timing fasting or postprandial (same formula; required label). below_best_cutoff true iff cpri < 2.02 (ROC for later insulin therapy; 80.8% sensitivity, 63.3% specificity). Glucose mg/dL only. Not HOMA-IR, not a diabetes diagnosis, not C-peptide alone, and not an insulin order.
$0.005$0.007 Base1086 ms1 payers100% up - 75api.magentlab.com/api/calc/corrected_calciumPayne albumin-corrected calcium from total calcium and albumin. Deterministic published formula with citation; not a treatment recommendation.
$0.005$0.007 Base1113 ms1 payers100% up - 75api.magentlab.com/api/calc/choles_scoreBharamgoudar 2018 CholeS Table 3 score for elective laparoscopic cholecystectomy duration. Age, sex, indication, BMI, CBD diameter, gallbladder wall, pre-op CT, planned IOC, prior surgical admissions, ASA class. Max 20. Numeric total only; no duration bands. Not a booking, not Nassar, not Tokyo. magent does not image the gallbladder.
$0.005$0.007 Base1315 ms1 payers100% up - 75api.magentlab.com/api/calc/tokyo_cholangitisKiriyama 2018 TG18 (=TG13) cholangitis. Definite if one A (fever/chills or elevated WBC/CRP), one B (jaundice or abnormal LFTs), and one C (dilatation or etiology); suspected if A plus B or C; else none. Grade III if any organ dysfunction, else Grade II if any two of WBC, fever >=39C, age >=75, bilirubin >=5, or hypoalbuminemia, else Grade I. Severity none if diagnosis none. Not cholecystitis or Alvarado/RIPASA. magent does not examine, assay, or read imaging. Not a medical device.
$0.005$0.007 Base1337 ms1 payers100% up - 75api.magentlab.com/api/calc/tokyo_cholecystitisYokoe 2018 TG18 (=TG13) acute cholecystitis. Definite if local signs (Murphy or RUQ mass/pain/tenderness), systemic signs (fever, elevated CRP or WBC), and imaging; suspected if local and systemic without imaging; else none. Suspected/definite: Grade III if any organ dysfunction, else Grade II if any Grade II flag, else Grade I. Severity none when diagnosis is none. Not cholangitis or Alvarado/RIPASA. magent does not examine, assay, or read imaging. Not a medical device.
$0.005$0.007 Base1333 ms1 payers100% up - 75api.magentlab.com/api/calc/travisTravis 1996 day-3 of intravenous steroids for severe ulcerative colitis. travis_high is true when stools_per_day > 8, or when stools_per_day is 3 to 8 inclusive and crp_mg_l > 45. Stools 8 with CRP 45 is not high. Stools 2 with high CRP is not high. Both parameters are required. Not a colectomy order, not the Ho score, and not Truelove and Witts. magent does not count stools or measure CRP.
$0.005$0.007 Base1772 ms1 payers100% up - 75api.magentlab.com/api/calc/truelove_wittsTruelove and Witts 1955 ulcerative colitis severity. severe iff stools_per_day >= 6 with macroscopic blood and at least one of fever, tachycardia, anemia, and esr_raised; mild iff stools_per_day <= 4, macroscopic_blood false, and no systemic flags; otherwise moderately_severe. Caller assigns flags from the 1955 table (fever mean evening >37.5 C or 37.8 C on 2 of 4 days; pulse >90; Hb 75% or less; ESR >30). magent does not examine the patient. Not a diagnosis, not Mayo UC, not PUCAI.
$0.005$0.007 Base1773 ms1 payers100% up - 75api.magentlab.com/api/calc/kruisKruis 1984 weighted IBS versus organic score. History: pain/flatulence/irregularity triad +34, duration >2 years +16, characteristic pain descriptors +23, alternating constipation/diarrhea +14. Organic flags: abnormal physical or pathognomonic history -47, ESR >10 mm/h -13, leukocytosis -50, anemia -98, blood in stool -98. IBS iff score >= 44. Caller assigns flags. magent does not examine the patient or run labs. Not a diagnosis, not Manning, not Rome.
$0.005$0.007 Base1289 ms1 payers100% up - 75api.magentlab.com/api/calc/manningManning 1978 IBS symptoms. Six caller-assigned flags, 1 each, max 6: visible abdominal distension, pain relief with bowel movement, more frequent stools at pain onset, looser stools at pain onset, rectal mucus, incomplete evacuation. Score is the count of true flags (0-6). More symptoms made IBS more likely; no published cutoff. Count only. Not a diagnosis, not Rome III/IV. magent does not examine the patient.
$0.005$0.007 Base1519 ms1 payers100% up - 75api.magentlab.com/api/calc/bristol_stoolLewis 1997 Bristol stool form scale: caller-assigned stool_type 1-7. Returns the assigned type and the published form wording (hard lumps like nuts through watery, entirely liquid). Stool form correlates with whole-gut transit time. magent does not inspect stool. Not a diagnosis, not constipation or diarrhea bands, and not a Rome IBS subtype.
$0.005$0.007 Base1638 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_child_constipationHyams 2016 Rome IV H3a. rome_iv_child_constipation is true iff developmental_age_at_least_4_years, duration_at_least_1_month, features_met >= 2, insufficient_criteria_for_ibs, and not_explained_by_another_condition. features_met always counts all six H3a flags (no G7 toilet-trained extras). Weekly frequency is folded into those flags. Caller assigns flags including large_fecal_mass_in_rectum. magent does not examine the child. Not a diagnosis, not infant G7, not adult Rome IV FC.
$0.005$0.007 Base1678 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_child_fap_nosHyams 2016 Rome IV H2d child FAP-NOS. rome_iv_child_fap_nos is true iff episodic_or_continuous_abdominal_pain_not_solely_during_physiologic_events, pain_at_least_4_times_per_month, insufficient_criteria_for_ibs_fd_or_abdominal_migraine, not_explained_by_another_condition, and fulfilled_at_least_2_months. Caller assigns five flags including the IBS/FD/abdominal-migraine residual. magent does not re-run those tools. Not a diagnosis, not adult CAPS, not FAPS (dropped in Rome IV).
$0.005$0.007 Base2061 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_child_abdominal_migraineHyams 2016 Rome IV H2c. rome_iv_child_abdominal_migraine is true iff paroxysmal intense periumbilical, midline, or diffuse pain lasting 1 hour or more, episodes weeks to months apart, incapacitating stereotypical pain, associated_features_met at least 2 (anorexia, nausea, vomiting, headache, photophobia, pallor), not explained by another condition, and 6-month fulfillment. Count 0-6. magent does not examine the child. Not a diagnosis. Not child CVS. Not adult migraine scores.
$0.005$0.007 Base1611 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_child_ibsHyams 2016 Rome IV H2b. rome_iv_child_ibs is true iff pain at least 4 days per month, stool_features_met >= 1, pain_does_not_resolve_with_constipation_treatment, not another condition, and 2-month duration. stool_features_met (0-3) counts related_to_defecation, change_in_stool_frequency, and change_in_stool_form. Caller assigns seven flags. magent does not examine the patient. Not a diagnosis. Not adult Rome IV IBS, not child functional constipation, not IBS-C/D/M/U subtype.
$0.005$0.007 Base1527 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_child_dyspepsiaHyams 2016 Rome IV H2a. True iff bothersome ≥4 days/month, symptoms_met ≥1 of 3 (postprandial fullness, early satiation, epigastric pain or burning not associated with defecation), exclusion, and 2-month duration. Item 4 is the exclusion, not a fourth symptom. PDS and EPS supportive features are copy-only. Caller assigns six flags. magent does not examine the child or parse EGD. Not a diagnosis. Not adult Rome IV FD.
$0.005$0.007 Base1526 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_child_ruminationHyams 2016 Rome IV H1c child rumination. rome_iv_child_rumination is true iff repeated_regurgitation_rechewing_or_expulsion_soon_after_meals, does_not_occur_during_sleep, not_preceded_by_retching, not_explained_by_another_condition_or_eating_disorder, and fulfilled_at_least_2_months. GERD-treatment failure and weekly frequency are not required. Manometry is not parsed. Caller assigns five flags. magent does not observe regurgitation. Not a diagnosis, not adult Rome IV rumination, not neonate G2.
$0.005$0.007 Base1292 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_child_cvsHyams 2016 Rome IV H1a child/adolescent cyclic vomiting. rome_iv_child_cvs is true iff two_or_more_periods_intense_nausea_paroxysmal_vomiting_hours_to_days_within_6_months, episodes_stereotypical, episodes_separated_weeks_to_months_with_return_to_baseline, and not_attributed_to_another_condition. Caller assigns four flags. magent does not examine the child. Not a diagnosis, not neonate/toddler G3, not adult Rome IV CVS, not cannabinoid hyperemesis.
$0.005$0.007 Base1951 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_pancreatic_sodCotton 2016 Rome IV E2 pancreatic sphincter of Oddi disorder. rome_iv_pancreatic_sod is true iff documented recurrent episodes of pancreatitis, other etiologies of pancreatitis excluded, negative endoscopic ultrasound, and abnormal sphincter manometry. Caller assigns four flags. magent does not read EUS, manometry, labs, or imaging. Not a diagnosis, not biliary SOD, not functional gallbladder, not a sphincterotomy recommendation.
$0.005$0.007 Base1679 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_biliary_sodCotton 2016 Rome IV E1b functional biliary SOD (former SOD type II). rome_iv_biliary_sod iff six E1 biliary-pain flags, enzymes XOR dilated bile duct, and no stones or other structural abnormalities. Type I (both findings) is organic stenosis, not this box. Type III (neither) is not this box. Supportive amylase/lipase, manometry, and scintigraphy are reported, not required. magent does not read labs, imaging, manometry, or ERCP. Not a diagnosis, not pancreatic SOD, not functional gallbladder.
$0.005$0.007 Base1356 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_functional_gallbladderCotton 2016 Rome IV E1a functional gallbladder disorder. rome_iv_functional_gallbladder is true iff nested E1 biliary pain and absence of gallstones or other structural pathology. low_ef_on_gallbladder_scintigraphy and normal_liver_enzymes_conjugated_bilirubin_amylase_lipase are supportive and not required. Caller assigns nine flags. magent does not read ultrasound, EUS, or HIDA or decide cholecystectomy. Not a diagnosis, not biliary SOD, not pancreatic SOD.
$0.005$0.007 Base1509 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_biliary_painCotton 2016 Rome IV E1 biliary pain. rome_iv_biliary_pain is true iff epigastric or RUQ pain builds to a 30-min steady level, occurs at different intervals (not daily), interrupts activities or leads to an ED visit, and is not significantly related to bowel movements or relieved by posture or acid suppression. Supportive flags reported, not required. magent does not examine the patient or read ultrasound, HIDA, or ERCP. Not a diagnosis, not functional gallbladder, not biliary or pancreatic SOD.
$0.005$0.007 Base1918 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_functional_defecationRao 2016 Rome IV F3. rome_iv_functional_defecation is true iff FC and/or IBS-C, at least two of three evacuation tests (balloon expulsion, manometry or anal surface EMG, imaging), last-3-months criteria, and 6-month onset. evacuation_tests_met is 0-3. magent does not perform those tests. Not a diagnosis. Not F3a or F3b as separate diagnoses.
$0.005$0.007 Base1520 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_levator_aniRao 2016 Rome IV levator ani syndrome. rome_iv_levator_ani is true iff chronic or recurrent rectal pain or aching, episodes lasting 30 minutes or longer, tenderness during puborectalis traction (caller assigns; magent does not perform traction), other causes of rectal pain excluded, last-3-months criteria, and 6-month onset. Not a diagnosis, not proctalgia fugax, not unspecified functional anorectal pain (F2b).
$0.005$0.007 Base1243 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_fecal_incontinenceRao 2016 Rome IV fecal incontinence. rome_iv_fecal_incontinence is true iff recurrent uncontrolled passage of fecal material, developmental age at least 4 years, last-3-months criteria, and 6-month onset. The research 2–4 episodes in 4 weeks frequency remark is copy-only and not parsed. magent does not examine the patient or read manometry. Not a diagnosis, not pediatric nonretentive fecal incontinence (H3b), not Wexner constipation score.
$0.005$0.007 Base1161 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_nbsKeefer 2016 Rome IV NBS (D2). rome_iv_nbs is true iff chronic or frequently recurring abdominal pain on narcotics, pain not explained by a GI diagnosis, at least two of three NBS features, last-3-months criteria, and 6-month onset. nbs_features_met is 0-3. Caller assigns seven flags. ~75 mg oral morphine equivalent is copy-only. magent does not examine the patient or judge opioid dose. Not a diagnosis, not CAPS, not opioid-induced constipation.
$0.005$0.007 Base1819 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_ruminationStanghellini 2016 Rome IV rumination syndrome. rome_iv_rumination is true iff persistent or recurrent regurgitation of recently ingested food with subsequent spitting or remastication and swallowing, regurgitation not preceded by retching, last-3-months criteria, and 6-month onset. Supportive remarks (effortless, not preceded by nausea, recognizable food, ceases when acidic) are copy-only and not parsed. magent does not observe regurgitation. Not a diagnosis, not CHS, not CVS, not GERD.
$0.005$0.007 Base1582 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_cnvsStanghellini 2016 Rome IV chronic nausea vomiting syndrome (CNVS, B3a). rome_iv_cnvs is true iff bothersome nausea at least 1 day per week and/or one or more vomiting episodes per week as one flag, self-induced vomiting eating disorders regurgitation and rumination excluded, no organic systemic or metabolic explanation including at upper endoscopy, last-3-months criteria, and 6-month onset. magent does not take a history or read endoscopy. Not a diagnosis, not CVS, not CHS, not rumination.
$0.005$0.007 Base1582 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_cvsStanghellini 2016 Rome IV adult CVS B3b. rome_iv_cvs is true iff stereotypical acute vomiting episodes lasting <1 week, ≥3 discrete episodes in the prior year and 2 in 6 months at least 1 week apart, absence of vomiting between episodes, last-3-months criteria, and 6-month onset. migraine_history is supportive and not required. Caller assigns eight flags. magent does not examine the patient. Not a diagnosis, not CHS, not pediatric CVS, not Rome IV IBS.
$0.005$0.007 Base1660 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_chsStanghellini 2016 Rome IV CHS. rome_iv_chs is true iff stereotypical episodic vomiting resembling CVS, presentation after prolonged excessive cannabis use, relief with sustained cannabis cessation, criteria fulfilled for the last 3 months, and onset at least 6 months prior. pathologic_bathing is supportive and not required. Caller assigns six flags. magent does not take a cannabis history. Not a diagnosis, not cyclic vomiting syndrome.
$0.005$0.007 Base1581 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_functional_dysphagiaAziz 2016 Rome IV functional dysphagia. rome_iv_functional_dysphagia is true iff sense of food sticking or passing abnormally, no mucosal or structural abnormality, not explained by GERD or eosinophilic esophagitis, no major esophageal motor disorder, last-3-months criteria, and 6-month onset. Caller assigns six flags. magent does not read barium, endoscopy, or manometry. Not a diagnosis, not globus, not oropharyngeal dysphagia. Minor or borderline motor disorders remain compatible.
$0.005$0.007 Base1723 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_reflux_hypersensitivityAziz 2016 Rome IV reflux hypersensitivity. rome_iv_reflux_hypersensitivity is true iff retrosternal heartburn or chest pain, normal endoscopy without EoE, no motor disorder, reflux-triggered despite normal acid, 3- and 6-month timing. Caller assigns six flags. magent does not read pH-impedance or endoscopy. Antisecretory response does not exclude the diagnosis and is not a required flag. Not a diagnosis, not functional heartburn, not GERD/NERD as the primary tool, not globus.
$0.005$0.007 Base1575 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_chest_painAziz 2016 Rome IV functional chest pain. rome_iv_chest_pain is true iff retrosternal chest pain or discomfort, no associated heartburn or dysphagia, not explained by GERD or eosinophilic esophagitis, no major esophageal motor disorder, last-3-months criteria, and 6-month onset. Caller assigns six flags, including cardiac rule-out. magent does not examine the patient, rule out ACS, or read manometry. Not a diagnosis, not functional heartburn, not reflux hypersensitivity, not globus.
$0.005$0.007 Base1717 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_heartburnAziz 2016 Rome IV functional heartburn. rome_iv_heartburn is true iff burning retrosternal discomfort, no relief despite optimal antisecretory therapy, not explained by GERD or eosinophilic esophagitis, no major esophageal motor disorder, last-3-months criteria, and 6-month onset. Caller assigns six flags. magent does not prescribe PPI or read pH-impedance. Not a diagnosis, not globus, not reflux hypersensitivity, not Rome IV IBS.
$0.005$0.007 Base1713 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_globusAziz 2016 Rome IV esophageal globus. rome_iv_globus is true iff nonpainful lump or foreign-body sensation, occurrence between meals, no dysphagia or odynophagia, no gastric inlet patch, not explained by GERD or EoE, no major esophageal motor disorder, last-3-months criteria, and 6-month onset. Caller assigns eight flags. magent does not examine the patient or read endoscopy. Not a diagnosis, not functional heartburn, not Rome IV IBS, not CHS.
$0.005$0.007 Base1765 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_oicMearin 2016 Rome IV C6 OIC. rome_iv_oic is true iff new or worsening constipation when initiating, changing, or increasing opioid therapy, at least 2 of 6 symptoms (straining, lumpy/hard stools, incomplete evacuation, anorectal obstruction, manual maneuvers, fewer than 3 SBM/week), and loose stools rare without laxatives. symptom_count is 0-6. Caller assigns eight flags. magent does not examine the patient or prescribe opioids. Not a diagnosis, not functional constipation C2, not IBS, not child.
$0.005$0.007 Base1766 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_unspecified_bowelMearin 2016 Rome IV C5 unspecified functional bowel. rome_iv_unspecified_bowel is true iff bowel symptoms not attributable to an organic etiology, does not meet criteria for IBS, functional constipation, functional diarrhea, or functional bloating/distension, last-3-months criteria, and 6-month onset. Caller assigns seven flags; magent does not re-score IBS/FC/diarrhea/bloating. Residual C5 only. Not a diagnosis. magent does not examine the patient.
$0.005$0.007 Base1695 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_bloatingMearin 2016 Rome IV C4 bloating/distension. rome_iv_bloating is true iff last-3-months criteria with 6-month onset, recurrent bloating or distension ≥1 day/week that predominates, and insufficient criteria for IBS, functional constipation, functional diarrhea, or PDS. Caller assigns three flags. magent does not examine the patient. Not a diagnosis. Adult C4 only. Not child, not IBS, not functional constipation, not functional diarrhea, not PDS or functional dyspepsia.
$0.005$0.007 Base1651 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_diarrheaMearin 2016 Rome IV C3 functional diarrhea. rome_iv_diarrhea is true iff last-3-months criteria with 6-month onset, loose or watery stools without predominant abdominal pain or bothersome bloating in >25% of stools, and insufficient criteria for diarrhea-predominant IBS. Caller assigns three flags. magent does not examine the patient. Not a diagnosis. Adult C3 only. Not child G5, not IBS-D, not Rome IV IBS, not Manning, not functional constipation.
$0.005$0.007 Base1727 ms1 payers100% up - 75api.magentlab.com/api/calc/wexner_constipationAgachan 1996 constipation scoring system from eight caller-assigned table bands (frequency, painful evacuation, incomplete evacuation, abdominal pain, time per attempt, assistance 0-2, unsuccessful attempts per 24 hours, duration). Total 0-30. constipation true iff score > 15. magent does not take a bowel history. Not a medical device, not a laxative order, not Jorge 1993 fecal incontinence scoring.
$0.005$0.007 Base1947 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_fcMearin 2016 Rome IV C2 FC. rome_iv_fc is true iff last-3-months criteria with 6-month onset, at least 2 of 6 symptoms (straining, lumpy/hard stools, incomplete evacuation, anorectal obstruction, manual maneuvers, fewer than 3 SBM/week), loose stools rare without laxatives, and insufficient IBS criteria. symptom_count is 0-6. Caller assigns nine flags. magent does not examine the patient. Not a diagnosis, not Rome IV IBS, not Manning, not opioid-induced or child constipation.
$0.005$0.007 Base1926 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_belchingStanghellini 2016 Rome IV belching disorders (B2). rome_iv_belching is true iff bothersome (severe enough to impact usual activities) belching from the esophagus or stomach more than 3 days a week, last-3-months criteria, 6-month onset, and belching_origin supragastric (B2a) or gastric (B2b). magent does not measure impedance or take a history. Not a diagnosis, not adult aerophagia, not child H1d aerophagia, not bloating, not FD.
$0.005$0.007 Base1798 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_fdStanghellini 2016 Rome IV B1 FD. rome_iv_fd is true iff last-3-months criteria with 6-month onset, no structural disease likely to explain symptoms, and PDS (B1a) and/or EPS (B1b). pds iff fullness and/or early satiation >=3 days/week. eps iff epigastric pain and/or burning >=1 day/week. Overlap allowed. Caller assigns six flags. magent does not examine the patient. Not a diagnosis, not Rome III dyspepsia, not Rome IV IBS.
$0.005$0.007 Base1915 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iv_ibsMearin 2016 Rome IV IBS. rome_iv_ibs is true iff recurrent abdominal pain at least 1 day per week in the last 3 months, onset at least 6 months prior, and at least two of: related to defecation, change in stool frequency, and change in stool form. supporting_features_met is 0-3. Caller assigns five flags. magent does not examine the patient. Not a diagnosis, not Rome III, not IBS subtype.
$0.005$0.007 Base1758 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_iii_ibsLongstreth 2006 Rome III IBS. rome_iii_ibs is true iff pain or discomfort at least 3 days per month in the last 3 months, onset at least 6 months prior, and at least two of: improvement with defecation, change in stool frequency, and change in stool form. supporting_features_met is 0-3. Caller assigns five flags. magent does not examine the patient. Not a diagnosis, not Rome IV, not IBS subtype.
$0.005$0.007 Base1910 ms1 payers100% up - 75api.magentlab.com/api/calc/rome_ii_ibsThompson 1999 Rome II IBS. rome_ii_ibs is true iff at least 12 weeks (need not be consecutive) in the preceding 12 months of abdominal discomfort or pain and at least two of: relieved with defecation, onset associated with a change in stool frequency, and onset associated with a change in stool form. supporting_features_met is 0-3. Caller assigns four flags. magent does not examine the patient. Not a diagnosis, not Rome III, not Rome IV, not Manning, not IBS subtype.
$0.005$0.007 Base1906 ms1 payers100% up - 75api.magentlab.com/api/calc/cdaiBest 1976 Crohn's disease activity index (CDAI): eight weighted variables (7-day liquid stools *2, abdominal-pain sum *5, well-being sum *7, extra-intestinal count *20, antidiarrheal *30, abdominal mass 0/2/5 *10, hematocrit deficit *6, caller-assigned weight-percent deviation). magent returns the rounded integer index only and does not apply later trial activity bands. magent does not examine the patient. Not a Crohn's diagnosis and not the Harvey-Bradshaw one-day index.
$0.005$0.007 Base1762 ms1 payers100% up - 75api.magentlab.com/api/calc/erefsHirano 2013 modified EREFS: caller-assigned edema (absent 0, present 1), rings (none 0, mild 1, moderate 2, severe 3), exudates (none 0, mild_lt_10pct 1, severe_gt_10pct 2), furrows (absent 0, present 1; original 0-2 collapsed), stricture (absent 0, present 1). magent sums only (max 8; not later 0-9). No activity bands, inflammatory/fibrostenotic subscores, crepe-paper, or narrow-calibre. magent does not perform endoscopy. Not a diagnosis.
$0.005$0.007 Base1768 ms1 payers100% up - 75api.magentlab.com/api/calc/uceisTravis 2013 UCEIS: caller-assigned vascular_pattern (normal 0, patchy 1, obliterated 2), bleeding (none 0, mucosal 1, luminal_mild 2, luminal_moderate_or_severe 3), erosions_ulcers (none 0, erosions 1, superficial_ulcer 2, deep_ulcer 3) at the worst-affected sigmoidoscopy segment. magent sums only (max 8; 2013 0-8 recode, not 2012 3-11) with no activity bands. magent does not perform endoscopy. Not Mayo DAI, MES, or Travis 1996 day-3. Not a diagnosis.
$0.005$0.007 Base1198 ms1 payers100% up - 75api.magentlab.com/api/calc/mayo_ucSchroeder 1987 ulcerative colitis disease-activity index (Mayo DAI): four caller-assigned integers 0-3 (stool frequency, rectal bleeding, endoscopy, physician global). magent sums only (max 12) and does not return later remission or activity-band cutoffs. magent does not count stools, examine the patient, or perform endoscopy. Not a diagnosis and not the Mayo SPN pulmonary-nodule model.
$0.005$0.007 Base1846 ms1 payers100% up - 75api.magentlab.com/api/calc/harvey_bradshawHarvey and Bradshaw 1980 simple Crohn's-disease activity index (one-day; items 1-3 previous day). Well-being 0-4, abdominal pain 0-3, liquid stools (1 point each; magent clamp 0-30), abdominal mass 0-3, plus 1 per listed complication (arthralgia, uveitis, erythema nodosum, aphthous ulcers, pyoderma gangrenosum, anal fissure, new fistula, abscess). magent sums only (max 48) and does not return later remission cutoffs. Not a Crohn's diagnosis or Best 1976 CDAI. magent does not examine the patient.
$0.005$0.007 Base1620 ms1 payers100% up - 75api.magentlab.com/api/calc/pucaiTurner 2007 pediatric ulcerative colitis activity index (PUCAI): six caller-assigned item points (abdominal pain, rectal bleeding, stool consistency of most stools, stools per 24 hours, nocturnal stools, activity level) using that paper's published integers. magent sums only (max 85) and returns the published activity band (<10 remission, 10-34 mild, 35-64 moderate, ≥65 severe). magent does not examine the child. Not a diagnosis and not the adult Mayo score.
$0.005$0.007 Base1523 ms1 payers100% up - 75api.magentlab.com/api/calc/pragueSharma 2006 Prague C and M. Caller-assigned circumferential c_cm and maximal m_cm (integers 0-20 cm above the gastroesophageal junction). Returns C{c}M{m} (for example C2M5). M must be ≥ C. C=0 is tongues only (no circumferential Barrett). Not a Barrett diagnosis; histology is required. Not Los Angeles oesophagitis grading. magent does not perform endoscopy. Not a medical device.
$0.005$0.007 Base1677 ms1 payers100% up - 75api.magentlab.com/api/calc/la_gradingLundell 1999 Table 1 Los Angeles classification. Caller-assigned flags. none if no mucosal break (not minimal changes); D if break(s) involve ≥75% of circumference; C if continuous between fold tops but <75%; B if longest break >5 mm not between fold tops; A if ≤5 mm not between fold tops. magent does not interpret images. Not Savary-Miller, GERD diagnosis, Barrett/stricture, or 1994 LA (D was fully circumferential). Not a medical device.
$0.005$0.007 Base1520 ms1 payers100% up - 75api.magentlab.com/api/calc/fistula_riskCallery 2013 Fistula Risk Score after pancreatoduodenectomy: gland texture firm 0 / soft 2; pathology PDAC or pancreatitis 0 / other (ampullary, duodenal, cystic, islet cell) 1; duct mm ≥5 0, ≥4 1, ≥3 2, ≥2 3, else 4; EBL mL ≤400 0, 401–700 1, 701–1000 2, >1000 3. Max 10. Bands negligible 0, low 1–2, intermediate 3–6, high 7–10. magent does not palpate the gland or measure EBL. Not a CR-POPF diagnosis, not an ISGPS grade, not Ranson or BISAP. Not a medical device.
$0.005$0.007 Base1607 ms1 payers100% up - 75api.magentlab.com/api/calc/forrestForrest 1974 endoscopic ulcer class as assigned by the caller: ia active spurting haemorrhage, ib active oozing, iia non-bleeding visible vessel, iib adherent clot, iic flat pigmented haematin / coffee-ground base, iii clean ulcer base. Returns the canonical class and 1974 lesion description. magent does not interpret endoscopy images or invent rebleeding percentages. Not a medical device.
$0.005$0.007 Base1947 ms1 payers100% up - 75api.magentlab.com/api/calc/hapsHAPS (Lankisch 2009). Harmless iff rebound tenderness and/or guarding is absent, hematocrit is normal, and serum creatinine is normal. The caller assigns each flag as already determined. magent does not examine the abdomen and does not measure hematocrit or creatinine. No millimetre or sex lab cutoffs. Not a medical device, not a diagnosis, and not a discharge order.
$0.005$0.007 Base2639 ms1 payers100% up - 75api.magentlab.com/api/calc/glasgow_imrieBlamey 1984 Glasgow-Imrie eight-factor pancreatitis score: age >55, WBC >15 ×10^9/L, glucose >10 mmol/L, urea >16 mmol/L, PaO2 <60 mm Hg, calcium <2.0 mmol/L, albumin <32 g/L, LDH >600 U/L; 1 point each, max 8. Severe predicted if score ≥3. Caller-assigned flags; magent does not convert units. Not a diagnosis. Not Ranson. Transaminases omitted as in the paper.
$0.005$0.007 Base1039 ms1 payers100% up - 75api.magentlab.com/api/calc/ap_predictionJin 2018 ED model for early diagnosis of acute pancreatitis when lipase is at least 3x ULN. Integer points: prior episodes 0/1/2/3/4, cholelithiasis +2, abdominal surgery in 2 months -2, epigastric pain +2, worsening pain +1, pain duration >=5 days -1, severity mild 0 / moderate +2 / severe +3, lipase fold +0/+1/+2. Score max 14; jin2018_high_ppv if score>=8; jin2024_accuracy_cut if score>=6. Not a diagnosis. Not an imaging order. Not Ranson, BISAP, or Glasgow-Imrie.
$0.005$0.007 Base1673 ms1 payers100% up - 75api.magentlab.com/api/calc/ransonRanson 1974 pancreatitis score from eleven published signs (five at admission, six at 48 hours) as boolean flags. Returns points 0-11 and mortality band 0-2 / 3-4 / 5-6 / 7-11. Deterministic published arithmetic with citation; not an ICU order.
$0.005$0.007 Base1209 ms1 payers100% up - 75api.magentlab.com/api/calc/bisapWu 2008 BISAP for early mortality prediction in acute pancreatitis: BUN >25 mg/dL, caller-assigned impaired mental status, caller-assigned SIRS, age >60, and caller-assigned pleural effusion; 1 point each, max 5. BUN 25.0 and age 60 do not score. Score only; no mortality percentages. Not a diagnosis. Not Ranson, APACHE II, or CTSI. magent does not recompute SIRS, assign mental status, or read imaging.
$0.005$0.007 Base1648 ms1 payers100% up - 75api.magentlab.com/api/calc/egusBrindle 2021 Edinburgh gastric ulcer score (human gastric ulcer at index OGD): age <68 → 0, 68-79 → 1, ≥80 → 2; size <1.25 cm → 0, 1.25-2.99 cm → 2, ≥3.00 cm → 3 (no 1-point size band); antral 0, non-antral 1. Total 0-6. higher_malignancy_risk iff score ≥ 3. Use only with macroscopically benign appearance and ≥6 negative biopsies. magent does not read endoscopy images. Not equine EGUS. Not a medical device.
$0.005$0.007 Base1436 ms1 payers100% up - 75api.magentlab.com/api/calc/rockallRockall 1996 complete (post-endoscopy) score after acute upper GI haemorrhage: age <60 0, 60-79 1, >=80 2; shock SBP<100 2 (hypotension; tachycardia not added), else HR>=100 1, else 0; comorbidity none 0, cardiac 2, renal/liver/metastatic 3; diagnosis none or mallory_weiss 0, other 1, malignancy 2; stigmata none_or_spot 0, blood_clot_vessel 2. Max 11. Not pre-endoscopy-only Rockall, AIMS65, or GBS. Caller assigns comorbidity, diagnosis, and stigmata.
$0.005$0.007 Base1449 ms1 payers100% up - 75api.magentlab.com/api/calc/rockall_preRockall 1996 pre-endoscopy (admission) score after acute upper GI haemorrhage: age <60 0, 60-79 1, >=80 2; shock SBP<100 2 (hypotension; tachycardia not added), else HR>=100 1, else 0; comorbidity none 0, cardiac (failure, IHD, or any major) 2, renal/liver/metastatic 3. Max 7. Not complete Rockall, AIMS65, or GBS. Caller assigns comorbidity.
$0.005$0.007 Base1440 ms1 payers100% up - 75api.magentlab.com/api/calc/nafld_nasKleiner 2005 NAFLD activity score (NAS): caller-assigned steatosis 0-3 (<5% / 5–33% / >33–66% / >66%), lobular_inflammation 0-3 (none / <2 foci per 200× / 2–4 / >4), ballooning 0-2 (none / few / many or prominent). magent sums only (max 8). Fibrosis is not in NAS. Kleiner 2005 reported NAS ≥5 correlated with NASH in that study; that is not a diagnostic algorithm. magent does not read histology and does not return NASH bands.
$0.005$0.007 Base1434 ms1 payers100% up - 75api.magentlab.com/api/calc/bardHarrison 2008 BARD score for NAFLD advanced fibrosis: BMI ≥28 kg/m² (1), AST/ALT ≥0.8 (2), diabetes mellitus (1); max 4. Low 0–1, high 2–4 (paper 2–4 vs 0–1 split). Not a NASH diagnosis; magent does not interpret a biopsy or compute BMI. Not FIB-4, APRI, or the NAFLD fibrosis score.
$0.005$0.007 Base1367 ms1 payers100% up - 75api.magentlab.com/api/calc/mrecistLencioni 2010 mRECIST for typical intrahepatic HCC target lesions. First-match: PD if new_lesion or a 20% or greater viable-sum increase vs nadir; else CR if arterial enhancement disappeared in all targets; else PR if a 30% or greater viable-sum decrease vs baseline; else SD. Caller-assigned flags; magent does not read imaging. Not a medical device, not a diagnosis, not RECIST 1.1, not EASL necrosis-only, not the 2019 Llovet +5 mm PD refinement, and not nontarget-only overall response.
$0.005$0.007 Base1368 ms1 payers100% up - 75api.magentlab.com/api/calc/bclcReig 2022 BCLC stage 0/A/B/C/D from caller-assigned cancer-related ECOG, preserved liver function, transplant option, vascular invasion, extrahepatic disease, tumor count, and largest diameter. Returns stage and expected median survival only. Not a treatment recommendation. magent does not assign ECOG, compute Child-Pugh, or interpret imaging. Not a medical device. Not Milan or UCSF listing.
$0.005$0.007 Base1521 ms1 payers100% up - 75api.magentlab.com/api/calc/metroticket_2Mazzaferro 2018 Metroticket 2.0 AFP-adjusted-to-HCC-size 70% 5-year HCC-specific survival criteria. meets_70pct_hcc_specific_survival is true iff AFP <200 ng/mL and tumor_count + largest_cm <=7, or 200<=AFP<400 and sum <=5, or 400<=AFP<=1000 and sum <=4. AFP >1000 never meets. Not Milan, UCSF, Metroticket 1.0 contours, or competing-risk survival percents. magent does not interpret imaging or assay AFP. Not a medical device or transplant listing.
$0.005$0.007 Base1367 ms1 payers100% up